Articles & Press Releases

Recent Articles

Dr. Ronald M. Fairman Elected SVS 2016 President

Press Release

[[{"type":"media","view_mode":"media_large","fid":"840","attributes":{"alt":"","class":"media-image","height":"480","style":"width: 177px; height: 198px; float: left; margin-left: 8px; margin-right: 8px;","typeof":"foaf:Image","width":"430"}}]]CHICAGO, Ill., July 11, 2016  — Vascular surgeon

New PAD Reporting Standards Recommended

Article

The variety of endovascular devices and techniques to treat occlusive disease has exploded over the past 10 years and critical evaluation of the reported results may be problematic. The Society for Vascular Surgery has released new reporting standards focused on endovascular treatment of chronic lower extremity peripheral artery disease. Recommended reporting standards for lower extremity ischemia were last published by the SVS in 1997.

Dr. Bruce Perler's Presidential Address

Article

The unique relationship that vascular surgeons enjoy with their patients has enabled our specialty to have a special claim on the way we care for patients. Outgoing SVS President Bruce Perler spoke during the 2016 Vascular Annual Meeting near Washington, D.C. on June 10.

Ken Slaw, PhD., named executive director of SVS

Press Release

CHICAGO, Illinois, May 6, 2016 –The Society for Vascular Surgery Board of Directors is pleased to announce Kenneth M. Slaw, Ph.D., as the society’s next executive director, replacing Rebecca Maron, CAE, who will retire May 30, 2016.  

Study: Too many patients don't get statins or AP after vascular surgery

Press Release

A recent review of patients who had undergone carotid, lower extremity bypass, or abdominal aortic aneurysm surgeries found that patients who received both statins and antiplatelet medications were far more likely to be alive five years later. Patients placed on both an antiplatelet agent and cholesterol medication had an adjusted 40 percent reduced risk of death at five years compared to those who received neither drug. Being on either one of these medications was also important, and was associated with an adjusted 30 percent reduced risk of death compared to those on neither medication. When considered differently, an extra 14 of every 100 patients were alive at five years if on both medications.

Rebecca Maron retiring as Executive Director of SVS

Press Release

Executive search firm conducting national search for new director

 

CHICAGO, Illinois - Society for Vascular Surgery Executive Director Rebecca Maron has announced her retirement, effective the end of May. She has served in that position for 13 years.

3 Things You Should Ask Before Surgery

Press Release

All too often patients say they are "blindsided" by unexpected outcomes of surgery. SVS member Dr. Margaret "Gretchen" Schwarze has won a prestigious PCORI grant to study ways to help patients understand what major surgery will mean to them.

SVS, APMA and SVM Publish First-Ever Guidelines for Treating Diabetic Foot

Press Release

The Society for Vascular Surgery, the American Podiatric Medical Association and the Society for Vascular Medicine collaboratively have published their first-ever set of clinical practice guidelines for treating the diabetic foot, based on a meta-analysis of the available literature. The guidelines, “The Management of the Diabetic Foot,” were developed after three years of study and were published online in late January and in print in the February 2016 edition of Journal for Vascular Surgery.

Recent Articles

Carotid controversy: Medication alone may not eliminate stroke risk

Press Release

Recent advances in statins and other medications have led some researchers to suggest that surgical treatments for carotid stenosis should be limited to symptomatic patients – primarily those who have already had a stroke or TIA. However, a new study published in the Journal of Vascular Surgery questions whether medical therapy is a sufficient stroke-reduction strategy. In the study, only 35 percent of stroke patients were receiving both statin and antiplatelet agents prior to their event, suggesting that asymptomatic carotid disease is unrecognized in many individuals, noted lead researcher Dr. W. Darrin Clouse of Massachusetts General Hospital. “And the first manifestation of their disease,” he wrote, “could be the occurrence of a stroke.”

SVS responds to opioid crisis bill

Article

[[{"fid":"2002","view_mode":"default","fields":{"format":"default","alignment":"","field_file_image_alt_text[und][0][value]":false,"field_file_image_title_text[und][0][value]":false},"link_text":null,"type":"media","field_deltas":{"1":{"format":"default","alignment":"","field_file_image_alt_text

Recent Articles

Carotid controversy: Medication alone may not eliminate stroke risk

Press Release

Recent advances in statins and other medications have led some researchers to suggest that surgical treatments for carotid stenosis should be limited to symptomatic patients – primarily those who have already had a stroke or TIA. However, a new study published in the Journal of Vascular Surgery questions whether medical therapy is a sufficient stroke-reduction strategy. In the study, only 35 percent of stroke patients were receiving both statin and antiplatelet agents prior to their event, suggesting that asymptomatic carotid disease is unrecognized in many individuals, noted lead researcher Dr. W. Darrin Clouse of Massachusetts General Hospital. “And the first manifestation of their disease,” he wrote, “could be the occurrence of a stroke.”

SVS responds to opioid crisis bill

Article

[[{"fid":"2002","view_mode":"default","fields":{"format":"default","alignment":"","field_file_image_alt_text[und][0][value]":false,"field_file_image_title_text[und][0][value]":false},"link_text":null,"type":"media","field_deltas":{"1":{"format":"default","alignment":"","field_file_image_alt_text